Treatment Considerations in Tumor-Related Epilepsy

Pallud J, Roux A, Moiraghi A, Aboubakr O, Elia A, Guinard E, et al. Characteristics and prognosis of tumor-related epilepsy during tumor evolution in patients with IDH wild-type glioblastoma. Neurology. 2024;102(1):e207902. https://doi.org/10.1212/WNL.0000000000207902.

Article  PubMed  CAS  Google Scholar 

Audrey C, Lim KS, Ahmad Zaki R, Fong SL, Chan CY, Sathis Kumar T, et al. Prevalence of seizures in brain tumor: a meta-analysis. Epilepsy Res. 2022;187:107033. https://doi.org/10.1016/j.eplepsyres.2022.107033.

Article  PubMed  Google Scholar 

Ollila L, Roivainen R. Glioma features and seizure control during long-term follow-up. Epilepsy Behav Rep. 2023;21:100586. https://doi.org/10.1016/j.ebr.2023.100586.

Article  PubMed  PubMed Central  Google Scholar 

Mortazavi A, Fayed I, Bachani M, Dowdy T, Jahanipour J, Khan A, et al. IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation. Neuro Oncol. 2022;24(9):1423–35. https://doi.org/10.1093/neuonc/noac003.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Neal A, Kwan P, O’Brien TJ, et al. IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy. Epilepsy Behav. 2018;78:30–6.

Article  PubMed  Google Scholar 

Osswald M, Jung E, Sahm F, et al. Brain tumour cells interconnect to a functional and resistant network. Nature. 2015;528(7580):93–8.

Article  PubMed  CAS  Google Scholar 

Chen H, Judkins J, Thomas C, et al. Mutant IDH1 and seizures in patients with glioma. Neurology. 2017;88(19):1805–13.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yang Y, Mao Q, Wang X, Liu Y, Mao Y, Zhou Q, Luo J. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy. J Clin Neurosci. 2016;31:56–62. Epub 2016 Jul 9. PMID: 27406953.

Article  PubMed  CAS  Google Scholar 

Phan K, Ng W, Lu VM, McDonald KL, Fairhall J, Reddy R, Wilson P. Association between IDH1 and IDH2 mutations and preoperative seizures in patients with Low-Grade versus High-Grade glioma: A systematic review and Meta-Analysis. World Neurosurg. 2018;111:e539–45. Epub 2017 Dec 27. PMID: 29288860.

Article  PubMed  Google Scholar 

Aboubakr O, Houillier C, Alentorn A, Choquet S, Dupont S, Mokhtari K, et al. Epilepsy in patients with primary CNS lymphoma: prevalence, risk factors, and prognostic significance. Neurology. 2024;103(5):e209748. https://doi.org/10.1212/WNL.0000000000209748.

Article  PubMed  Google Scholar 

Wang Y, Qian T, You G, Peng X, Chen C, You Y, et al. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro Oncol. 2015;17(2):282–8. https://doi.org/10.1093/neuonc/nou130.

Article  PubMed  Google Scholar 

Suri A, Mahapatra AK, Bithal P. Seizures following posterior fossa surgery. Br J Neurosurg. 1998;12(1):41–4. https://doi.org/10.1080/02688699845500.

Article  PubMed  CAS  Google Scholar 

Goertz L, Bernards N, Muders H, Hamisch C, Goldbrunner R, Krischek B. Incidence and clinical presentation of Pre- and postoperative seizures in patients with posterior fossa meningiomas. Cureus. 2024;16(1):e52474. https://doi.org/10.7759/cureus.52474. PMID: 38371129; PMCID: PMC10873762.

Article  PubMed  PubMed Central  Google Scholar 

Rilinger RG, Guo L, Sharma A, Volovetz J, Thompson NR, Grabowski M, et al. Tumor-related epilepsy in high-grade glioma: a large series survival analysis. J Neurooncol. 2024;170(1):153–60. https://doi.org/10.1007/s11060-024-04787-z.

Article  PubMed  PubMed Central  Google Scholar 

Rossi J, Cavallieri F, Bassi MC, Venturelli F, Toschi G, Di Rauso G, et al. To be or not to be: the dilemma over the prognostic role of epilepsy at presentation in patients with glioblastoma - a systematic review and meta-analysis. BMC Cancer. 2024;24(1):1488. https://doi.org/10.1186/s12885-024-13249-8.

Article  PubMed  PubMed Central  Google Scholar 

Jo J, Nevel K, Sutyla R, Smolkin M, Lopes MB, Schiff D. Predictors of early, recurrent, and intractable seizures in low-grade glioma. Neuro-oncol Pract. 2020;8(1):40–7. https://doi.org/10.1093/nop/npaa054.

Article  Google Scholar 

Santos-Pinheiro F, Park M, Liu D, Kwong LN, Cruz S, Levine NB, et al. Seizure burden pre- and postresection of low-grade gliomas as a predictor of tumor progression in low-grade gliomas. Neuro-Oncol Pract. 2019;6(3):209–17. https://doi.org/10.1093/nop/npy022.

Article  Google Scholar 

Mirsattari SM, Chong JJ, Hammond RR, Megyesi JF, Macdonald DR, Lee DH, et al. Do epileptic seizures predict outcome in patients with oligodendroglioma? Epilepsy Res. 2011;94(1–2):39–44. https://doi.org/10.1016/j.eplepsyres.2011.01.001.

Article  PubMed  Google Scholar 

Mann C, Conradi N, Neuhaus E, Konczalla J, Freiman TM, Spyrantis A, et al. Early epilepsy surgery in benign cerebral tumors: avoid your ‘Low-Grade’ becoming a ‘Long-Term’ epilepsy-Associated tumor. J Clin Med. 2022;11(19):5892. https://doi.org/10.3390/jcm11195892.

Article  PubMed  PubMed Central  Google Scholar 

Stritzelberger J, Gesmann A, Fuhrmann I, Uhl M, Brandner S, Welte TM, Schembs L, Dörfler A, Coras R, Adler W, Schwab S, Putz F, Fietkau R, Distel L, Hamer H. The course of tumor-related epilepsy in glioblastoma patients: A retrospective analysis. Epilepsy Behav. 2024;158:109919. Epub 2024 Jun 27. PMID: 38941953.

Article  PubMed  Google Scholar 

Lersch R, Hartlieb T, Pieper T, Kudernatsch M, Hofer W, Barba C, et al. Seizure outcomes following epilepsy surgery in pediatric and young adult patients with high-grade brain tumors: results from a European survey. Epilepsia. 2025;66(6):1865–75. https://doi.org/10.1111/epi.18323.

Article  PubMed  PubMed Central  Google Scholar 

Feyissa AM. Wild seizing Gliomas! Time-Dependent characteristics and prognosis of Glioblastoma-Related epilepsy. Epilepsy Curr. 2024;24(4):271–3. PMID: 39309056; PMCID: PMC11412406.

Article  PubMed  PubMed Central  Google Scholar 

Toledo M, Sarria-Estrada S, Quintana M, Maldonado X, Martinez-Ricarte F, Rodon J, Auger C, Salas-Puig J, Santamarina E, Martinez-Saez E. Prognostic implications of epilepsy in glioblastomas. Clin Neurol Neurosurg. 2015;139:166–71. Epub 2015 Oct 22. PMID: 26489387.

Article  PubMed  Google Scholar 

Avila EK, Tobochnik S, Inati SK, Koekkoek JAF, McKhann GM, Riviello JJ, et al. Brain tumor-related epilepsy management: a Society for Neuro-oncology (SNO) consensus review on current management. Neuro Oncol. 2024;26(1):7–24. https://doi.org/10.1093/neuonc/noad154.

Article  PubMed  Google Scholar 

Walbert T, Harrison RA, Schiff D, Avila EK, Chen M, Kandula P, et al. SNO and EANO practice guideline update: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neuro Oncol. 2021;23(11):1835–44. https://doi.org/10.1093/neuonc/noab152.

Article  PubMed  PubMed Central  Google Scholar 

van der Meer PB, Kerkhof M, Dirven L, Fiocco M, Vos MJ, Kouwenhoven M, et al. Long-term follow-up results of antiseizure medication withdrawal in grade 2 and 3 glioma patients: a prospective observational study. Neurology. 2025;104(10):e213590. https://doi.org/10.1212/WNL.0000000000213590.

Article  PubMed  PubMed Central  Google Scholar 

Cardona AF, Rojas L, Wills B, Bernal L, Ruiz-Patiño A, Arrieta O, et al. Efficacy and safety of levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma. J Neurooncol. 2018;136(2):363–71. https://doi.org/10.1007/s11060-017-2660-0.

Article  PubMed  CAS  Google Scholar 

Kim YH, Kim T, Joo JD, Han JH, Kim YJ, Kim IA, et al. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme. Cancer. 2015;121(17):2926–32. https://doi.org/10.1002/cncr.29439.

Article  PubMed  CAS  Google Scholar 

Kerkhof M, Dielemans JC, van Breemen MS, Zwinkels H, Walchenbach R, Taphoorn MJ, Vecht CJ. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro Oncol. 2013;15(7):961–7. https://doi.org/10.1093/neuonc/not057. Epub 2013 May 16. PMID: 23680820; PMCID: PMC3688020.

Article  PubMed  PubMed Central 

Comments (0)

No login
gif